Is MDD a Chronic or Episodic Condition? Join Dr. Vlad Maletic and Dr. Michael Thase as they debate to classify MDD as a chronic or an episodic condition. Register now!
Is MDD a Chronic or Episodic Condition? Join Dr. Vlad Maletic and Dr. Michael Thase as they debate to classify MDD as a chronic or an episodic condition. Register now!
Andrew Penn, MS, PMHNP, Associate Clinical Professor, UCSF School of Nursing, discusses the impact of MDD on patients' self-image and factors that may have reduced stigma in recent years.
Andrew Penn, MS, PMHNP, Associate Clinical Professor, UCSF School of Nursing, discusses the impact of MDD on patients' self-image and factors that may have reduced stigma in recent years.
Efficacy and tolerability results were reported from phase 1 of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study, which compared first- and second-generation antipsychotic medication in people with schizophrenia.
Efficacy and tolerability results were reported from phase 1 of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study, which compared first- and second-generation antipsychotic medication in people with schizophrenia.
In this video, Kate Sullivan, MSN, APN, characterizes the lifetime course of major depressive disorder, discusses disease management, and addresses gaps in current knowledge where further research is needed.
In this video, Kate Sullivan, MSN, APN, characterizes the lifetime course of major depressive disorder, discusses disease management, and addresses gaps in current knowledge where further research is needed.
Biomarker research may help improve the precision of antidepressant prescribing and identify new drug targets for major depressive disorder. Read more here.
Biomarker research may help improve the precision of antidepressant prescribing and identify new drug targets for major depressive disorder. Read more here.